Regorafenib

ATC L01EX05 · 10 markets · 22 records

Regorafenib 10 markets · 22 records Forms

CN 11 records · 1 strengths

  • 40 mgtablet拜万戈瑞戈非尼__mah__:上海创诺制药有限公司、__mah__:南京正大天晴制药有限公司、__mah__:扬子江药业集团有限公司、__mah__:江西科睿药业有限公司、__mah__:湖南明瑞制药股份有限公司、__mah__:湖南科伦制药有限公司、__mah__:石药集团欧意药业有限公司、__mah__:重庆药友制药有限责任公司 +1 also in GB·AU·US +4

GB 2 records · 1 strengths

AU 2 records · 2 strengths

  • 40 mgtabletSTIVARGA regorafenib 40 mg tablet bottle also in CN·GB·US +4 unknown

Records without a stated strength · 1 Stivarga

US 1 records · 1 strengths

CA 1 records · 1 strengths

SG 1 records · 1 strengths

ES 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 Stivarga

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Stivarga

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.